The formulation you use, whether it is a brand-name pen, compounded vial, or specialty blend, affects your injection approach and your risk of accidental muscle injection
In addition, jumps in blood sugar may not be restricted to people with diabetes
Additionally, a high percentage of participants achieved a weight reduction of 5% or more (85% with 5 mg, 89% with 10 mg, and 91% with 15 mg of tirzepatide)
Quick Answer: Current clinical evidence does not establish a causal relationship between semaglutide use and increased blood clot formation
Studies have demonstrated that patients using semaglutide can lose an average of 14.9% of their body weight over 68 weeks , making it one of the most effective non-surgical weight loss solutions available today
However, it's important to monitor any changes and consult your healthcare provider if you're concerned